Semnur Pharmaceuticals, Inc. - Class A common stock, par value $0.0001 per share (DNQAF)

CUSIP: G6256B106

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Equity / Class A common stock, par value $0.0001 per share
Shares outstanding
1,261,821
Total 13F shares
7,971,555
Share change
+1,115,408
Total reported value
$83,347,055
Price per share
$10.47
Number of holders
32
Value change
+$11,706,832
Number of buys
10
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP G6256B106?
CUSIP G6256B106 identifies DNQAF - Semnur Pharmaceuticals, Inc. - Class A common stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Semnur Pharmaceuticals, Inc. - Class A common stock, par value $0.0001 per share (DNQAF) as of Q1 2023

As of 31 Mar 2023, Semnur Pharmaceuticals, Inc. - Class A common stock, par value $0.0001 per share (DNQAF) was held by 32 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,971,555 shares. The largest 10 holders included Polar Asset Management Partners Inc., Hudson Bay Capital Management LP, Periscope Capital Inc., ATW SPAC MANAGEMENT LLC, BOOTHBAY FUND MANAGEMENT, LLC, MIZUHO SECURITIES USA LLC, Saba Capital Management, L.P., Quarry LP, WOLVERINE ASSET MANAGEMENT LLC, and Calamos Advisors LLC. This page lists 32 institutional shareholders reporting positions in this security for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.